Solanezumab (Anti-Amyloid Beta)
Solanezumab (Anti-Amyloid Beta) is a humanized monoclonal IgG1 antibody targeting the mid-domain of the amyloid-β (Aβ) peptide. It has the potential for the research of Alzheimer’s disease. MW :144.34 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A3064 |
| Sku # | A3064-1mg*25 |
| Pricing | 1mg*25, $2970.00 |